Immunogenetic predictors of the development of bronchial obstruction during acute bronchitis in infants

Alexandr E Abaturov1, Olena O Rusakova1

  • 1State Institution "Dnipropetrovsk Medical Academy Of The Ministry Of Health Of Ukraine", Dnipro, Ukraine.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|April 6, 2020
PubMed

Insights

Predicting bronchial obstruction in infants with acute bronchitis is possible by measuring specific immune markers. Low levels of NF-κB and IL-12, along with an imbalance in IFN-γ and IL-13, indicate a higher risk.

Area of Science:

  • Pediatric immunology
  • Molecular genetics
  • Respiratory medicine

Background:

  • Acute bronchitis in infants can lead to bronchial obstruction, a serious complication.
  • Identifying predictive markers for bronchial obstruction is crucial for timely intervention.
  • Immune system dysregulation plays a significant role in the inflammatory process of acute bronchitis.

Purpose of the Study:

  • To identify key immunological and molecular genetic factors predicting bronchial obstruction in infants with acute bronchitis.
  • To assess the relationship between specific immune markers and the development of wheezing.

Main Methods:

  • Study included 120 infants (6 months to 3 years) diagnosed with acute bronchitis.
  • Measured NF-κB expression in lymphocytes via flow cytometry.
  • Quantified serum levels of interferon-gamma (IFN-γ), interleukins (IL-4, IL-12, IL-13), and total IgE using ELISA and ECLIA.

Main Results:

  • Low lymphocyte NF-κB expression (<49.8%) was associated with a high risk of bronchial obstruction (RR=3.27).
  • Specific serum concentrations of IL-12 (41.35-173.06 pg/ml) and IL-13 (4.06-6.71 pg/ml) served as early predictors of wheezing.
  • Elevated NF-κB expression (>0.91 Units), IFN-γ (>9.83 pg/ml), IL-12 (>173.06 pg/ml), and IL-13 (>6.71 pg/ml) significantly reduced the probability of wheezing.

Conclusions:

  • Development of bronchial obstruction in infants with acute bronchitis is linked to low NF-κB and IL-12 levels.
  • An imbalance in IFN-γ and IL-13 production is also associated with increased risk.
  • These immune markers can aid in predicting and managing bronchial obstruction in pediatric acute bronchitis.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
673
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K